L2 Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History

L2 Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $1.46 Million - $1.94 Million	-30,769 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $251,116 - $327,228	-5,360 Reduced 14.84%	30,769 $1.81 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $88,816 - $135,359	2,135 Added 6.28%	36,129 $1.71 Million
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $1.83 Million - $2.22 Million	33,994 New	33,994 $2.05 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.